San Francisco, Nov 15 The
global cell
counting market is expected to reach USD 10,679.7 million by
2025, according to a new report by Grand View Research, Inc. Government
initiatives working to promote development of cell therapeutics, wherein cell
counting plays an imperative role, is expanding growth prospects for the
market. As a result of extensive R&D activities, the number of diseases
treated with the help of stem cells increased to 82 in 2016 from 27 in 2005.
Also, California Institute for Regenerative Medicine’s funding of USD 271
million for stem cell therapy created 12 R&D facilities in California, and
these facilities brought approximately USD 543 million funding. In addition, it
is also funded by National Institutes of Health (NIH), which approximately
invested USD 1,429 million in 2015.
Increase
in the number of collaborations of research institutes with various public and
private entities to promote R&D has provided significant boost to the
market. Growing number of proposed guidelines and recommendations for public
and private laboratories to ensure high-quality standards and facilitate
generation of accurate results are likely to improve adoption of instruments
over the coming years. For instance, in May 2016, the International Society for
Stem Cell Research updated guidelines for the development of cell-based therapy
and research. The proposed guidelines focus on all stages of R&D and
improve quality of preclinical studies.
Browse full research report on Cell Counting Market:
www.grandviewresearch.com/industry-analysis/cell-counting-market
Further Key
Findings From the Report Suggest:
- Spectrophotometers
accounted forthe largest market share in 2016. This can be attributed to
high penetration in various applications such as toxicology studies,
bioprocessing, and others
- Automated
counters were anticipated to grow at an exponential rate during the
forecast period. Benefits such as short testing time, reduced error
occurrence, and interoperator variability are expected to further increase
demand for automated counters
- In the
end-use segment, research and academic institutes accounted for the
largest market share in 2016, owing to growing number of government
initiatives focused toward promoting R&D in various toxicology studies
- Research and
academic institutes are also expected to witness exponential growth
opportunities, owing to the growing adoption of instruments for optimum
drug concentration in therapeutics
- North America
held the largest share of the market, owing to increase in number of
supportive initiatives to fund R&D, which is anticipated to result in
higher adoption of automated instruments
- Asia Pacific
is anticipated to grow with a lucrative CAGR during the forecast period.
This lucrative growth rate is a consequence of improvements in testing
facilities
- Level of
competition is high as key players are adopting strategies such as new
product development and strategic collaborations & agreements to gain
competitive advantage
Browse more reports of this category
by Grand View Research: www.grandviewresearch.com/industry/medical-devices
Grand View Research has
segmented the global cell counting market on the basis of product, end use, and
region:
Cell Counting
Product Outlook (Revenue, USD Million, 2014 - 2025)
- Instruments
- Spectrophotometers
- Flow Cytometers
- Hematology Analyzers
- Cell Counters
- Consumables & Accessories
- Reagents
- Microplates
- Others
Cell Counting
End-use Outlook (Revenue, USD Million, 2014 - 2025)
- Hospitals & Diagnostic Laboratories
- Research & Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Others
Cell Counting
Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
- Saudi Arabia
Browse press release of this report
by Grand View Research: www.grandviewresearch.com/press-release/global-cell-counting-market
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research reports,
and consulting services. To help clients make informed business decisions, we
offer market intelligence studies ensuring relevant and fact-based research
across a range of industries, from technology to chemicals, materials and
healthcare.
For more information:
www.grandviewresearch.com
No comments:
Post a Comment